CLINICAL TRIAL / NCT06087029
IMPRoving Outcomes in Vascular DisEase - Aortic Dissection
- Interventional
- OPEN TO ACCRUAL
- NCT06087029
Contact Information
IMPRoving Outcomes in Vascular DisEase- Aortic Dissection
The goal of this clinical trial is to determine whether an upfront invasive strategy of TEVAR plus medical therapy reduces the occurrence of a composite endpoint of all-cause death or major aortic complications compared to an upfront conservative strategy of medical therapy with surveillance for deterioration in patients with uncomplicated type B aortic dissection.